Back to Results
First PageMeta Content
Auditing / Corporate governance / Regulation S-K / United States corporate law / Form 10-K / Angiogenesis / Aurora B kinase / Protein kinase inhibitor / U.S. Securities and Exchange Commission / SEC filings / United States securities law / Financial regulation


A Clinical Development CompanyForm 10-K EntreMed, Inc. (Nasdaq: ENMD) is a clinical-stage pharmaceutical company focused on developing
Add to Reading List

Document Date: 2014-05-14 13:07:09

Open Document

File Size: 674,69 KB

Share Result on Facebook
UPDATE